Emergent BioSolutions
EBS
#6960
Rank
NZ$0.97 B
Marketcap
NZ$18.28
Share price
-0.55%
Change (1 day)
34.41%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2025 (TTM): NZ$2.47

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is NZ$2.36. In 2024 the company made an earnings per share (EPS) of NZ-$6.07 an increase over its 2023 EPS that were of NZ-$24.89.

EPS history for Emergent BioSolutions from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$2.47-140.7%
2024NZ-$6.07-75.61%
2023NZ-$24.89232.21%
2022NZ-$7.49-203.46%
2021NZ$7.24-25.09%
2020NZ$9.67445.28%
2019NZ$1.77-15.2%
2018NZ$2.09-35.9%
2017NZ$3.2669.57%
2016NZ$1.92-27.67%
2015NZ$2.6665.63%
2014NZ$1.6111.63%
2013NZ$1.4432.31%
2012NZ$1.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.27-3.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.22 418.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.30 167.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ-$5.42-329.79%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.70-70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.65-339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.07-12.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel